Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

KESTINE TABLET 10 MG [SIN09435P]

Active ingredients: KESTINE TABLET 10 MG

View product's general information
Last updated 24 April 2026

Product Info

KESTINE TABLET 10 MG

[SIN09435P]

Product information

Active Ingredient and Strength

EBASTINE - 10 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

INDUSTRIAS FARMACEUTICAS ALMIRALL (IFA) S.A. - SPAIN

Registration Number

SIN09435P

Licence Holder

EURODRUG LABORATORIES SINGAPORE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

R06AX22

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

INDICATION:
10mg: Ebastine (Kestine®) is indicated in the treatment of allergic rhinitis (seasonal and perennial) with or without allergic conjunctivitis and chronic idiopathic urticaria.
20mg: Ebastine (Kestine®) is indicated in the treatment of allergic rhinitis (seasonal and perennial) with or without allergic conjunctivitis.

Dosing

DOSAGE AND ADMINISTRATION:
For oral use. Ebastine (Kestine®) film-coated tablets may be taken with or without food. Tablets must be swallowed whole with a small amount of water.

Adults and children over 12 years of age:

10mg:

  • Allergic Rhinitis: The usual dose is 10 mg of ebastine once daily. In the event of severe symptoms, the dose may be increased to 20 mg once daily.

  • Chronic Idiopathic Urticaria: A dose of 10 mg once daily.

20mg:

  • Allergic Rhinitis: The usual dose is 10 mg of ebastine once daily. In the event of severe symptoms, the dose may be increased to 20 mg once daily.

Children 12 years old and below

  • The safety of Ebastine (Kestine®) film-coated tablets has not been established for children under 12 years of age.

For elderly

  • not necessary to adjust dose.

For patients with renal impairment

  • not necessary to adjust dose

For patients with hepatic impairment

  • not necessary to adjust dose in patients with mild to moderate hepatic impairment. There is no experience with doses greater than 10 mg in patients with severe hepatic impairment.
    Therefore, the 10 mg dose should not be exceeded in patients with severe hepatic impairment.

Contraindications

CONTRAINDICATION:
Children under 12 due to a lack of efficacy and safety data
History of hypersensitivity to the active substance or to any of the excipients.